jan 24, 2018 - FDA and the Federal Trade Commission posted joint warning letters to the marketers and distributors of 12 opioid cessation products, for illegally marketing unapproved products with claims about their ability to help in the treatment of opioid addiction and withdrawal.
Added to timeline:
Date:
jan 24, 2018
Now
~ 8 years and 4 months ago